ASPIRE-2-PREVENT: lifestyle and risk factor management and use of cardioprotective medication in coronary patients in the UK
Publication
, Conference
Kotseva, K; Jennings, C; Turner, E; Wood, D
Published in: EUROPEAN HEART JOURNAL
2010
Duke Scholars
Published In
EUROPEAN HEART JOURNAL
ISSN
0195-668X
Publication Date
2010
Volume
31
Start / End Page
898 / 899
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Kotseva, K., Jennings, C., Turner, E., & Wood, D. (2010). ASPIRE-2-PREVENT: lifestyle and risk factor management and use of cardioprotective medication in coronary patients in the UK. In EUROPEAN HEART JOURNAL (Vol. 31, pp. 898–899).
Kotseva, K., C. Jennings, E. Turner, and D. Wood. “ASPIRE-2-PREVENT: lifestyle and risk factor management and use of cardioprotective medication in coronary patients in the UK.” In EUROPEAN HEART JOURNAL, 31:898–99, 2010.
Kotseva K, Jennings C, Turner E, Wood D. ASPIRE-2-PREVENT: lifestyle and risk factor management and use of cardioprotective medication in coronary patients in the UK. In: EUROPEAN HEART JOURNAL. 2010. p. 898–9.
Kotseva, K., et al. “ASPIRE-2-PREVENT: lifestyle and risk factor management and use of cardioprotective medication in coronary patients in the UK.” EUROPEAN HEART JOURNAL, vol. 31, 2010, pp. 898–99.
Kotseva K, Jennings C, Turner E, Wood D. ASPIRE-2-PREVENT: lifestyle and risk factor management and use of cardioprotective medication in coronary patients in the UK. EUROPEAN HEART JOURNAL. 2010. p. 898–899.
Published In
EUROPEAN HEART JOURNAL
ISSN
0195-668X
Publication Date
2010
Volume
31
Start / End Page
898 / 899
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology